d06a.jpg (14023 bytes)WideMed and SleepMed Collaborate
WideMed Ltd and SleepMed Inc, Seattle, have agreed to test, commercialize, and deploy WideMed’s Morpheus™, a signal processing technology for real-time analysis of complex biomedical signals. Morpheus interfaces with standard acquisition systems and generates reports pursuant to scoring rules and formats designated by users.

The companies will also work together to explore technology sharing in EEG monitoring. WideMed develops platforms for the remote diagnosis of sleep and cardiovascular disorders, and SleepMed is a provider of diagnostic and treatment services for sleep and seizure disorders.

d06a.jpg (14023 bytes)Focus Conference Heads to Nashville
Focus Journal presents the third annual FOCUS on Respiratory Care & Sleep Medicine conference for sleep technologists, therapists, nurses, and physicians on April 10-13, 2003, at the Opryland Hotel, Nashville, Tenn. The registration fee is $225 and will include 42 lectures, including, such speakers as William Dement, Meir Kryger, William Orr, Mary Carskadon, Sharon Keenan, Gary Greenburg, and Nick MacMillan.

Three meals, a night at the Grand Ole Opry, access to the exhibit hall with 150 exhibitors, door prizes, happy hours, caricature artists, live music, stilt walkers, and impersonators are all included in the registration fee, and the conference’s opening reception will offer free food, beer, and wine. The keynote address will be delivered by Naomi Judd. Rooms at the Opryland Hotel are $120 per night, and 15 continuing education units are available for each discipline. (800) 661-5690; www.foocus.com.  

InnoMed Signs 800th Sleep Disorder Facility
In a little more than 3 months, InnoMed Technologies Inc, Boca Raton, Fla, has signed agreements with more than 800 sleep disorder treatment facilities in the United States. Since January 2002, the company’s staff has grown by 45%, and its distributor sales force has increased by 185 in order to support the sales of the Nasal Aire Interface, InnoMed’s mask that has received positive support from the sleep and respiratory communities. www.innomedinc.com